TipRanks
Context Therapeutics (DE:6K9)
FRANKFURT:6K9
Germany Market
6K9
Context Therapeutics
RESEARCH TOOLSreports

Context Therapeutics (6K9) Income Statement

1 Followers

Context Therapeutics Income Statement

Last quarter (Q2 2026), Context Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Context Therapeutics's net income was $-14.56M. See Context Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 39.70M$ 29.92M$ 25.07M$ 15.38M$ 10.53M
Depreciation and Amortization
$ 16.25K$ 10.88K$ 12.04K$ 9.27K$ -3.09M
EBITDA
$ -36.11M$ -26.71M$ -23.95M$ -14.87M$ -10.53M
Operating Income
$ -39.70M$ -29.92M$ -25.07M$ -15.38M$ -10.53M
Other Income/Expenses
$ 3.58M$ 3.20M$ 1.11M$ 545.26K$ 68.95K
Pretax Income
$ -36.12M$ -26.73M$ -23.96M$ -14.84M$ -10.46M
Net Income
$ -36.12M$ -26.73M$ -23.96M$ -14.84M$ -10.46M
Per Share Metrics
Basic EPS
$ -0.38$ -0.46$ -1.50$ -0.93$ -3.69
Diluted EPS
$ -0.38$ -0.46$ -1.50$ -0.93$ -3.69
Weighted Average Shares Outstanding
 95.19M 58.42M 15.97M 15.97M 2.83M
Weighted Average Shares Outstanding (Diluted)
 95.19M 58.42M 15.97M 15.97M 2.83M
Currency in USD

Context Therapeutics Earnings and Revenue History